Cargando…
NLRP3 inflammasome activation and its inhibitory drugs in connection with COVID-19 infection
SARS-CoV-2 virus belongs to the beta coronavirus family that cause the inflammatory condition, acute pneumonia, and acute respiratory distress syndrome (ARDS). ARDS is the most important reason of mortality in patients, characterized as a highly increased levels of pro-inflammatory cytokine secretio...
Autores principales: | Zafar-Mohammadi, Khashayar, Poursamimi, Javad, Atabaki, Mahdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515760/ http://dx.doi.org/10.1177/1721727X221130984 |
Ejemplares similares
-
Inhibitory effect of PPARγ on NLRP3 inflammasome activation
por: Yang, Ching-Chun, et al.
Publicado: (2021) -
NLRP3, the inflammasome and COVID-19 infection
por: Yin, Maureen, et al.
Publicado: (2023) -
Macrophage migration inhibitory factor is required for NLRP3 inflammasome activation
por: Lang, Tali, et al.
Publicado: (2018) -
The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
por: Coll, Rebecca C., et al.
Publicado: (2011) -
Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention
por: Zhang, Jiayu, et al.
Publicado: (2023)